A multicenter, prospective, randomized, open-label, blinded endpoint trial of intravenous thrombolysis with tenecteplase for acute non-large vessel occlusion in extended time window (OPTION): Rationale and design. [PDF]
Ma G +13 more
europepmc +1 more source
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial. [PDF]
Wu Y +8 more
europepmc +1 more source
Safety and efficacy of intra-arterial tenecteplase for non-complete reperfusion of intracranial occlusions: Methodology of a randomized, controlled, multicenter study. [PDF]
Kaesmacher J +24 more
europepmc +1 more source
Prehospital thrombolysis with tenecteplase in out-of-hospital cardiac arrest: a retrospective cohort study. [PDF]
Cowley A +4 more
europepmc +1 more source
[Comparison of functional outcomes between tenecteplase and alteplase as bridging thrombolysis prior to mechanical throm-bectomy for acute ischemic stroke patients with large vessel occlusion]. [PDF]
Shi Z +8 more
europepmc +1 more source
Thrombolytic therapy in vertebrobasilar dolichoectasia patients with acute posterior circulation cerebral infarction: a case series analysis. [PDF]
Han Q +6 more
europepmc +1 more source
Tenecteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Wang Z +5 more
europepmc +1 more source
Seeing It Through - Lessons from a Retinal Stroke Trial. [PDF]
Schrag M, Mac Grory B.
europepmc +1 more source
Bridging thrombolysis versus direct thrombectomy in acute ischemic stroke with large vessel occlusion: a network meta-analysis. [PDF]
Huang J +7 more
europepmc +1 more source
The Importance of Cost-Effectiveness in New Drug Approval: Stroke Burden and Tenecteplase Efficacy. [PDF]
Kwon HS, Kim BJ.
europepmc +1 more source

